RADX

AS OF

Feb 4, 04:58 PM (EDT)

Price

$4.89

Change

+$0.02 (+0.41%)

Capitalization

37.83M

22 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

RADX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Radiopharm Theranostics (RADX) Ownership - Who owns Radiopharm Theranostics?

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

RADX

Capitalization

37.8M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

36.4M

Total Cash/Share

4.62

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.32%

Revenue

1.68M

ROE

N/A

Book Value

53.2M

P/B Ratio

1.23

Cash Flow

N/A

Earnings

-18.66

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

168M

Current Ratio

3.37

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-42.33M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-55.22

Shares Held By Institutions

1.73M

Shares Outstanding - Current

7.88M

Total Liabilities

40.4M

Total Volume MTD

N/A

Value

Gain YTD

-6.705

View a ticker or compare two or three

Compare

RADX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for RADX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details